Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v36-FR Version v7-EN
Language French English
Date Updated 2021-03-17 2020-09-01
Drug Identification Number 02450488 02450488
Brand name MYLAN-VERAPAMIL SR MYLAN-VERAPAMIL SR
Common or Proper name VERAPAMIL VERAPAMIL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE
Strength(s) 180MG 180MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code C08DA C08DA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-01-19 2020-10-13
Actual start date 2021-01-20
Estimated end date 2021-03-16 2020-11-24
Actual end date 2021-03-16
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments